US Broker Ratings

Ascentage Pharma Group Internat (AAPG) Stock Analysis: Uncovering a Potential 158% Upside

Ascentage Pharma Group International (AAPG), a clinical-stage biotechnology company headquartered in Suzhou, China, is capturing investor attention with its ambitious pipeline and substantial market potential. Focused..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Exploring a 150% Upside Potential in Biotechnology

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) presents a compelling case for investors in the healthcare sector, particularly those with an interest in biotechnology. With a market capitalization..

IDEAYA Biosciences (IDYA) Stock Analysis: Exploring a 47.49% Upside Potential

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a trailblazer in precision medicine oncology, is capturing the attention of investors with its promising pipeline and strategic collaborations. With a..

Kiniksa Pharmaceuticals (KNSA) Stock Analysis: Exploring a Compelling 8.86% Upside Potential

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) is drawing significant attention from investors within the healthcare sector. With a prominent focus on developing therapies for complex autoinflammatory..

Schrodinger, Inc. (SDGR) Investor Outlook: Evaluating a 37% Potential Upside Amidst Unconventional Valuation Metrics

Investors with a keen eye on the healthcare sector may want to take a closer look at Schrödinger, Inc. (NASDAQ: SDGR), a company that stands at..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Navigating Potential Amidst Revenue Growth and Analyst Consensus

Acadia Healthcare Company, Inc. (NASDAQ: ACHC), a key player in the U.S. behavioral healthcare sector, provides a comprehensive array of services aimed at addressing the mental..

Beam Therapeutics Inc. (BEAM) Stock Analysis: 98.66% Potential Upside Captivates Investors

Beam Therapeutics Inc. (NASDAQ: BEAM) stands at the forefront of innovation in the biotechnology sector, offering investors a unique opportunity with a potential upside of nearly..

Denali Therapeutics Inc. (DNLI): Analyst Consensus and Growth Potential Highlight a 49.56% Upside

Denali Therapeutics Inc. (NASDAQ: DNLI) stands at the forefront of the biotechnology sector, with a focus on developing innovative treatments for complex neurodegenerative and lysosomal storage..

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a 23.64% Potential Upside in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL), a notable player in the healthcare sector specializing in medical devices, presents a compelling opportunity for investors. Despite facing challenges reflected in..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Stability in Healthcare with a 21.2% Revenue Growth

LifeStance Health Group, Inc. (NASDAQ: LFST) has emerged as a notable player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Scottsdale,..

Concentra Group Holdings (CON) Stock Analysis: Strong Buy Ratings and a 6.60% Potential Upside

Concentra Group Holdings Parent, Inc. (CON), a prominent player in the healthcare sector, particularly in the medical care facilities industry, is capturing the attention of investors..

AtriCure, Inc. (ATRC) Stock Analysis: Strong Buy Ratings and 35% Upside Potential

AtriCure, Inc. (NASDAQ: ATRC) stands out in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $1.76 billion, AtriCure..

Sotera Health Company (SHC) Stock Analysis: Unpacking a 17.36% Potential Upside

Sotera Health Company (NASDAQ: SHC), a notable player in the healthcare sector, stands out with a promising 17.36% potential upside based on the current average analyst..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: Navigating Through a Sea of Potential with 2,873% Revenue Growth

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) has emerged as a notable player in the biotechnology sector, focusing primarily on rare endocrine diseases and endocrine-related tumors. With a..

MoonLake Immunotherapeutics (MLTX): Investor Outlook with a 46.98% Upside Potential

MoonLake Immunotherapeutics (NASDAQ: MLTX) is capturing the attention of investors with its promising pipeline in the biotechnology sector, specifically focusing on therapies for inflammatory skin and..

NovoCure Limited (NVCR) Stock Analysis: Exploring a 56% Upside Potential with Expanding Oncology Innovations

NovoCure Limited (NASDAQ: NVCR) stands at the forefront of medical innovation in the healthcare sector, particularly in the field of oncology. With its specialization in the..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Healthcare Innovator with 18% Upside Potential

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN) stands as a significant player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization..

SS Innovations International (SSII) Stock Analysis: Exploring an 86.67% Upside Potential in the Surgical Robotics Arena

SS Innovations International, Inc. (NASDAQ: SSII), a burgeoning player in the healthcare sector, operates within the medical devices industry with a laser focus on surgical robotics...

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Exploring an 84% Potential Upside in the Biotech Arena

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) has carved a niche in the biotechnology sector with its focus on rare and ultra-rare genetic diseases. For investors seeking opportunities..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: A Biotech Bet with a 137.70% Revenue Growth

Agios Pharmaceuticals, Inc. (AGIO), a dynamic player in the healthcare sector, is grabbing investor attention with its impressive revenue growth of 137.70%. As a biotechnology company..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds